Article info
Cardiovascular Disease Clinical Research
Related Pharmaceutical Clinical Research
GW24-e3561 Xuezhikang can reduce arterial stiffness in patients with essential hypertension, independent of lipid lowering effects
Citation
GW24-e3561 Xuezhikang can reduce arterial stiffness in patients with essential hypertension, independent of lipid lowering effects
Publication history
- First published October 1, 2013.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the bMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions